News

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...
Moving toward clinical development, the researchers demonstrated efficient delivery of mRNA mitochondrial base editors using lipid nanoparticles.
AI-powered ChemPerturb-seq reveals sex-specific cocktail improving islet transplant survival, offering a new treatment for type 1 diabetes.
EM, researchers elucidated the structure of key receptors integral to fast excitatory synaptic transmission in the rat cerebellum.
Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.
A recent research finding adds to evidence that brain inflammation is a major driver of neurodegenerative disorders such as ...
LOTTE will manufacture antibody drug substance for Ottimo Pharma’s product at LOTTE’s Syracuse Bio Campus in New York.
Illumina has entered into a definitive agreement with Standard BioTools under which the company will acquire SomaLogic.
The question for biomanufacturing leaders is no longer whether to modernize their scientific data infrastructure, but how ...
Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...
A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.